Swiss National Bank
CRMD icon

Swiss National Bank’s CorMedix CRMD Stock Holding History

Swiss National Bank’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.09M Sell
138,800
-7,400
-5% -$58.5K ﹤0.01% 2189
2026
Q1 		$993K Hold
146,200
– – ﹤0.01% 2160
2025
Q4 		$1.7M Hold
146,200
– – ﹤0.01% 1944
2025
Q3 		$1.7M Buy
146,200
+28,600
+24% +$346K ﹤0.01% 1933
2025
Q2 		$1.45M Hold
117,600
– – ﹤0.01% 1966
2025
Q1 		$724K Buy
+117,600
New +$1.22M ﹤0.01% 2263

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deep Track Capital
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Royce & Associates
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Oberweis Asset Management
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Swiss National Bank's CRMD Position: Q2 2026 in Review

Swiss National Bank reduced its CorMedix (CRMD) stake by 5.1% in Q2 2026, selling an estimated $58.5K and leaving 138,800 shares worth $1.09M. The position accounts for ﹤0.01% of the portfolio, ranked #2189.

Swiss National Bank first reported a position in CRMD in Q1 2025 and has held it in 6 quarters since. The position peaked at $1.7M in Q4 2025. 193 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Swiss National Bank held 138,800 shares of CorMedix worth $1.09M as of Q2 2026.
  • Swiss National Bank sold 7,400 CorMedix shares in Q2 2026, an estimated $58.5K.
  • CorMedix made up ﹤0.01% of Swiss National Bank's portfolio in Q2 2026, its #2189 holding.
  • Swiss National Bank first reported a position in CorMedix in Q1 2025 and has held it in 6 quarters since.
  • Swiss National Bank's CorMedix position peaked at $1.7M in Q4 2025.
  • 193 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Swiss National Bank's 13F filing for Q2 2026, filed 11 Aug 2026.